跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAC MEVON 600 MG EFFERVESCENCE TABLETS - HSA Drug Approval Details
Approvals
/
HSA
/
NAC MEVON 600 MG EFFERVESCENCE TABLETS
Approved
THERAPEUTIC
NAC MEVON 600 MG EFFERVESCENCE TABLETS
E-Pharma Trento S.p.A.
🇸🇬 Health Sciences Authority
Approval Date
Mar 15, 2019
Approval ID
44c6c20fb6f26b9f
Company
E-Pharma Trento S.p.A.
Type
Therapeutic
Approval Details
Approval Id
44c6c20fb6f26b9f
Drug Name
NAC MEVON 600 MG EFFERVESCENCE TABLETS
Product Name
NAC MEVON 600 MG EFFERVESCENCE TABLETS
Approval Number
SIN15645P
Approval Date
2019-03-15
Registrant
NOVEM PHARMA PRIVATE LIMITED
Licence Holder
NOVEM PHARMA PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
TABLET, EFFERVESCENT
Route Of Administration
ORAL
Atc Code
R05CB01
Atc Item Name
acetylcysteine
Pharma Manufacturer Name
NOVEM PHARMA PRIVATE LIMITED
Company Detail Path
/organization/novem-pharma-private-limited
Active Ingredients
Acetylcysteine
600mg
ACETYLCYSTEINE
600 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 15, 2019
Approval ID
44c6c20fb6f26b9f
Type
Therapeutic
Back to HSA Approvals